Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Reverse hybrid therapy is a one-step two-phase treatment for Helicobacter pylori infection
with less cost than standard triple therapy. Whether reverse hybrid therapy can replace
standard triple therapy as the recommended first-line treatment is unknown. The investigators
compared the efficacy of 12-day reverse hybrid therapy and 12-day standard triple therapy in
first-line treatment.
Phase:
N/A
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Collaborator:
Kaohsiung Medical University Chung-Ho Memorial Hospital